Related Experiment Videos

Outer membrane protein alterations in Serratia marcescens resistant against aminoglycoside and beta-lactam

Chemotherapy
|January 1, 1987
PubMed

Insights

Sequential Serratia marcescens isolates from one patient showed reduced susceptibility to key antibiotics. This change correlated with altered outer membrane proteins, suggesting a mechanism for antibiotic resistance development in respiratory infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biochemistry

Background:

  • Serratia marcescens is an opportunistic pathogen.
  • Antibiotic resistance is a growing global health concern.
  • Understanding resistance mechanisms is crucial for effective treatment.

Purpose of the Study:

  • To investigate the sequential development of antibiotic resistance in Serratia marcescens isolates from a single patient.
  • To identify potential molecular changes associated with decreased antibiotic susceptibility.

Main Methods:

  • Sequential isolation of Serratia marcescens from patient respiratory tract samples.
  • Phenotypic characterization of antibiotic susceptibility (amikacin, cefotaxime, lamoxactam).
  • Analysis of outer membrane protein profiles using SDS-PAGE.

Main Results:

  • Three initial 'opaque' (wild-type) isolates were susceptible to amikacin, cefotaxime, and lamoxactam.
  • Three subsequent 'gray' colony isolates exhibited reduced susceptibility to these antibiotics.
  • SDS-PAGE revealed three distinct alterations in outer membrane proteins in the less susceptible isolates.

Conclusions:

  • A shift in colony morphology in Serratia marcescens correlated with decreased antibiotic susceptibility.
  • Alterations in outer membrane proteins are associated with reduced susceptibility to amikacin, cefotaxime, and lamoxactam.
  • This study highlights potential mechanisms of antibiotic resistance acquisition in persistent infections.

Related Concept Videos